Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,"Adalimumab, etanercept and secukinumab","Psoriatic arthritis, SA review of number of csDMARDs previously trialled","Adalimumab, etanercept and secukinumab",Options for investment,Community and Hospital,Oncology Agents and Immunosuppressants
